CliffBio

Kyowa Kirin Co.

Patent cliffs & loss of exclusivity

Kyowa Kirin Co. is a Yamaguchi, Yamaguchi-based company in the pharmaceutical industry founded in 1941.

Company

Company Operating StatusActive
Seedtable URLhttps://seedtable.com/investors/kyowa-kirin-co
Official Websitehttps://www.kyowakirin.co.jp/about_us/group_domestic/index.html

6 upcoming patent cliffs

DrugIngredientTypeCliff
  1. NOURIANZISTRADEFYLLINESmall mol.Jan 2028
  2. NOURIANZISTRADEFYLLINESmall mol.Jan 2028
  3. Crysvitaburosumab-twzaBiologicApr 2030
  4. Crysvitaburosumab-twzaBiologicApr 2030
  5. Crysvitaburosumab-twzaBiologicApr 2030
  6. Poteligeomogamulizumab-kpkcBiologicAug 2030
  7. FARESTONTOREMIFENE CITRATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Kyowa Kirin Co. — patent cliffs & loss of exclusivity | CliffBio